Health Canada and TGA Regulatory Cooperation Initiative (RCI) project yielded labelling standard for oral adult expectorant containing guaifenesin as a single ingredient.

FDA released Guidance document on Global Unique Device Identification Database (GUDID) intended primarily to provide information about submitting data to the database for device Labelers, entities responsible for submitting data to the GUDID.

2 recent FDA Class II Special Controls Guideline for Industry and Food and Drug Administration Staff released on May 30th 2014:

Home  |  About Us |  Services  |  Resources  |  Updates |  Contact Us

Copyright © Reg-Affairs & QualiPractixis Inc. 2014. All right reserved.